What oral oxycodone regimen corresponds to morphine 4 mg intravenous every 4 hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Opioid Conversion: IV Morphine to Oral Oxycodone

Convert morphine 4 mg IV every 4 hours to oral oxycodone 20 mg every 4 hours.

Conversion Calculation

Starting with morphine 4 mg IV every 4 hours:

  • Total daily IV morphine dose: 4 mg × 6 doses = 24 mg/day
  • Convert IV morphine to oral morphine: Using the standard 1:3 ratio 1, 24 mg IV morphine = 72 mg oral morphine daily
  • Convert oral morphine to oral oxycodone: Using the 1:1.5 ratio 2, 72 mg oral morphine ÷ 1.5 = approximately 48 mg oral oxycodone daily
  • Divided dosing: 48 mg ÷ 6 doses (every 4 hours) = 8 mg oral oxycodone every 4 hours

However, applying a more conservative approach with the alternative conversion method:

  • Using the direct IV morphine to oral oxycodone conversion factor of approximately 1.2:1 3, 24 mg IV morphine × 1.2 = approximately 29 mg oral oxycodone daily
  • This translates to approximately 5 mg oral oxycodone every 4 hours

Recommended Starting Dose

Start with oral oxycodone 5-10 mg every 4 hours, with close titration based on response 4. Given the patient is already on scheduled opioids (not opioid-naïve), starting at 10 mg every 4 hours is reasonable, but err on the conservative side initially.

Key Conversion Principles

The NCCN guidelines 1 establish that:

  • IV to oral morphine conversion uses a factor of 3 (10 mg IV morphine = 30 mg oral morphine)
  • Oral morphine to oral oxycodone uses approximately 1:1.5 ratio
  • Critical caveat: "It is safer to underestimate a patient's 24-hour oxycodone dosage than to overestimate" 4

Titration Strategy

  • Initial dose: Start with 5-10 mg oral oxycodone every 4 hours around-the-clock 4
  • Monitor closely: Assess pain control and side effects within the first 24-72 hours
  • Breakthrough dosing: Provide 10-15% of total daily dose as immediate-release oxycodone for breakthrough pain 1
  • Upward titration: Increase by 25-50% if inadequate analgesia after 24 hours

Important Clinical Considerations

Pharmacokinetic advantages of oxycodone 5, 6:

  • Higher oral bioavailability (60-87%) compared to morphine (20%)
  • More predictable metabolism
  • Faster onset of action (1 hour vs morphine)
  • Reaches steady state within 24 hours (vs 2-7 days for morphine)

Mandatory co-prescribing:

  • Laxative regimen: Must be initiated immediately as 60.6% of oxycodone prescriptions lack this 7
  • Multimodal analgesia: Combine with non-opioid analgesics (acetaminophen, NSAIDs if appropriate)

Common Pitfalls to Avoid

  1. Over-conversion: The relative potency varies with dose and duration; chronic dosing shows different ratios than acute conversion 8
  2. Renal impairment: Both morphine and oxycodone require caution; consider dose reduction by 25-50% if creatinine clearance <30 mL/min 1
  3. Immediate vs controlled-release confusion: The conversion above is for immediate-release oxycodone every 4 hours; if converting to controlled-release, give every 12 hours at half the calculated total daily dose per administration 4

Monitoring Parameters

  • Pain intensity scores every 4 hours initially
  • Sedation level (primary safety concern in first 72 hours) 4
  • Respiratory rate (maintain >10 breaths/minute)
  • Bowel function daily
  • Adjust dose if inadequate analgesia or excessive side effects within 24-48 hours

References

Guideline

adult cancer pain, version 2.2025, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2025

Research

Oxycodone: a pharmacological and clinical review.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2007

Research

Oxycodone controlled release in cancer pain management.

Therapeutics and clinical risk management, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.